The European Industrial Pharmacists Group (EIPG) presents its November newsletter, offering a comprehensive update on the latest developments and opportunities in the pharmaceutical and healthcare industries. This regular publication is an essential resource for staying informed about regulatory changes, research initiatives, and educational opportunities tailored for EIPG members.
Highlights in this edition include:
- Mario Draghi’s Report: A focus on strategies to close the EU innovation gap with the US and China through systemic reforms, decarbonization, and robust supply chain management.
- EU Supply Chain Law: Details on the CSDDD directive and its implications for environmental and human rights monitoring across value chains, set for gradual implementation from 2027.
- ACT-EU Initiative: Updates on the transformation of clinical trials in the EU, with emphasis on safer drug development and modern methodologies.
- Future R&D Programs: Insights into the post-2024 EU election agenda, featuring Horizon Europe 2025 and FP10, focusing on innovation, sustainability, and increased investment in research.
EIPG members also benefit from exclusive discounts on training modules, such as the on-demand course on EU GMP Annex 1 compliance.
Don’t miss out on opportunities for professional growth and insight into industry advancements. Stay connected with EIPG for regular updates and access to dedicated information and training opportunities.
Read the newsletter: Newsletter eipg_November_2024_new
